BOSOX
Price
$18.75
Change
-$0.17 (-0.90%)
Updated
Sep 20 closing price
FSSNX
Price
$27.77
Change
-$0.31 (-1.10%)
Updated
Sep 20 closing price
Ad is loading...

BOSOX vs FSSNX

Header iconBOSOX vs FSSNX Comparison
Open Charts BOSOX vs FSSNXBanner chart's image
Boston Trust Walden Small Cap
Price$18.75
Change-$0.17 (-0.90%)
VolumeN/A
CapitalizationN/A
Fidelity Small Cap Index
Price$27.77
Change-$0.31 (-1.10%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
BOSOX vs FSSNX Comparison Chart
Loading...
VS
BOSOX vs. FSSNX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BOSOX is a Buy and FSSNX is a StrongBuy.

FUNDAMENTALS
Fundamentals
FSSNX has more cash in the bank: 27.3B vs. BOSOX (1.42B). FSSNX pays higher dividends than BOSOX: FSSNX (1.36) vs BOSOX (0.44). BOSOX was incepted earlier than FSSNX: BOSOX (19 years) vs FSSNX (13 years). BOSOX is a more actively managed with annual turnover of: 23.98 vs. FSSNX (9.00). FSSNX has a lower initial minimum investment than BOSOX: FSSNX (0) vs BOSOX (100000). FSSNX annual gain was more profitable for investors over the last year : 22.65 vs. BOSOX (17.94). FSSNX return over 5 years is better than : 44.62 vs. BOSOX (29.03).
BOSOXFSSNXBOSOX / FSSNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years13 years-
Gain YTD9.7709.97298%
Front LoadN/AN/A-
Min. Initial Investment1000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.42B27.3B5%
Annual Yield % from dividends0.441.3633%
Returns for 1 year17.9422.6579%
Returns for 3 years2.910.65448%
Returns for 5 years29.0344.6265%
Returns for 10 years28.9084.2434%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RLMD3.490.05
+1.45%
Relmada Therapeutics
BSAC20.240.18
+0.90%
Banco Santander-Chile
ODC67.85-0.79
-1.15%
Oil-Dri Corp
HRMY38.34-0.47
-1.21%
Harmony Biosciences Holdings
THAR2.94-0.05
-1.67%
Tharimmune Inc.